Salivary α-amylase and cortisol after exercise in menopause: influence of long-term HRT
Authors:
- C. M. GhiciucCGC. M. Ghiciuc
- M. BernardiMBM. Bernardi
- L. C. Dima-CozmaLDL. C. Dima-Cozma
- L. FattoriniLFL. Fattorini
- M. R. SqueoMSM. R. Squeo
- P. GaloppiPGP. Galoppi
- R. BrunelliRBR. Brunelli
- F. FerranteFFF. Ferrante
- V. PasqualiVPV. Pasquali
- G. PerroneGPG. Perrone
- 24 February 2015
- journal article
- research article
- Published by Taylor & Francis in Climacteric
- Vol. 18 (4) , 528-535
Abstract
This observational prospective study analyzed the effect of an incremental cardiopulmonary exercise test (CPET) on the secretion of salivary biomarkers of the adrenergic nervous system and hypothalamus-pituitary-adrenal (HPA) axis activity by measuring salivary α-amylase and cortisol diurnal trajectories in the setting of long-term hormone replacement therapy (HRT). Fifteen healthy sedentary postmenopausal women who were current HRT users and 15 women who had never used HRT were consecutively recruited. α-Amylase and cortisol were measured in salivary samples collected on the CPET day and on a rest day. Cardiovascular and respiratory fitness parameters were recorded during the CPET challenge. The participants had very homogeneous somatic characteristics, and they were all in generally good health. The postmenopausal never-HRT users presented an abnormal diurnal pattern of α-amylase at baseline and a flattened response to CPET. In contrast, women on HRT had a physiological α-amylase diurnal pattern and increased salivary α-amylase production during the CPET-induced challenge. The CPET challenge physiologically activated the HPA axis activity, as shown by the increase in the concentration of salivary cortisol during the effort test. HPA axis activity was not affected by long-term HRT. Postmenopausal women using HRT exhibited a cardiorespiratory functional capacity that was significantly (p < 0.05) higher than that of non-users. Our findings show that healthy postmenopausal women present an asymmetry between adrenergic nervous system and HPA axis activities under both basal and stress conditions. HRT was able to modify the abnormal adrenergic nervous system activity, most likely by reducing the sympathetic hyperactivity that characterizes menopause.Keywords
This publication has 45 references indexed in Scilit:
- EMAS position statement: Managing the menopause in the context of coronary heart diseaseMaturitas, 2011
- Sex, hormones and neuroeffector mechanismsActa Physiologica, 2010
- Hot Flashes and Subclinical Cardiovascular DiseaseCirculation, 2008
- Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progressionMenopause, 2007
- Menopause, mild psychological stress and salivary cortisol: Influence of long-term hormone replacement therapy (HRT)Maturitas, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Transdermal Estrogen Replacement Therapy Decreases Sympathetic Activity in Postmenopausal WomenCirculation, 2001
- Acute electrophysiologic effect of estradiol 17β in menopausal womenThe American Journal of Cardiology, 2000
- Evidence of a role of endogenous estrogen in the modulation of autonomic nervous systemThe American Journal of Cardiology, 2000
- Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal womenAmerican Heart Journal, 1999